Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-001 · synthetic case FX-014

Amiodarone-associated overt biochemical pattern

On amiodarone: TSH 11.2 and FT4 0.6.

Synthetic · no real patientReviewed acceptance scenarioThyroid engine v1.1.0

Purpose: Detect functional pattern and show medication etiology modifier.

Inputs the engine received

Patient

Age and sex
60, male

Medications

Amiodarone
Yes

Symptoms

Fatigue
Present
Weight gain
Present

Laboratory

TSH
11.2 mIU/L (ref 0.4–4.5)
FT4
0.6 ng/dL (ref 0.8–1.8)
ANTI-TPO
10 IU/mL (ref 0–35)

What the engine reports

Caution

Caution

A medication or exposure relevant to thyroid interpretation is documented. Review its possible contribution before assigning a final etiology or management pathway.

Detected clinical pattern

Biochemical Pattern Compatible with Overt Primary Hypothyroidism

Elevated TSH with FT4 below the laboratory reference range supports this pattern.

  • Etiology / context: Medication/Exposure Modifier Present

Why this pattern was identified

  • Elevated TSH with low FT4. TSH 11.2 mIU/L (ref 0.4–4.5) and FT4 0.6 ng/dL (ref 0.8–1.8).
  • Medication/exposure documented. Amiodarone

Context modules routed

  • CTX-HT-DRUG Medication / Exposure Modifier

    Flag possible drug- or exposure-associated thyroid dysfunction; do not automatically assign autoimmune etiology; consider specialist review for complex medication-related patterns.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Confirm clinical context, etiology modifiers and medication/exposure history.
  2. 2Consider lipid panel, CBC and CK if clinically indicated.
  3. 3Physician to determine levothyroxine initiation and dose using age and cardiovascular context.
Evidence and rule trace · 2 rules

PR-HT-01Overt Primary Hypothyroidism Biochemical Pattern

Inputs: TSH 11.2 mIU/L (ref 0.4–4.5) · FT4 0.6 ng/dL (ref 0.8–1.8)

TSH above and FT4 below the laboratory reference range.

CTX-HT-DRUGMedication / Exposure Modifier

Context module routed.

Evidence

  • EV-AACE-ATA-2012 · Garber JR et al. Clinical Practice Guidelines for Hypothyroidism in Adults. Endocr Pract. 2012;18(6):988-1028.
  • EV-ATA-HYPO-2014 · Jonklaas J et al. Guidelines for the Treatment of Hypothyroidism. Thyroid. 2014;24(12):1670-1751.

Physician adjudication required. For clinician review only. This output identifies clinical patterns and safety considerations from the documented inputs. It does not establish an autonomous diagnosis or treatment plan. Physician confirmation is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Thyroid-function testsMove the sliders or type values
  • below range
  • within range
  • above range
  • below range
  • within range
  • above range
TSH11.2 mIU/L · above reference
ref 0.44.5
Free T40.6 ng/dL · below reference
ref 0.81.8
Where this sits on the TSH × FT4 plane
Overt primarySubclinicalDiscordantCentral?EuthyroidDiscordantCentral?Low TSHThyrotoxicTSH ↑FT4 →

Zones are drawn from your reference intervals. The engine, not the map, decides the pattern.

Laboratory values and reference rangesUse your lab's own interval
Ref. low
Ref. high

µIU/mL and mIU/L are numerically identical.

Ref. low
Ref. high
Ref. low
Ref. high

Interpreted against the reporting assay's upper limit.

Ref. low
Ref. high

Only used in the thyrotoxicosis pathway.

Ref. low
Ref. high
Ref. low
Ref. high
Ref. low
Ref. high
Ref. low
Ref. high
Patient context
Sex at birth
Medications and exposures
Symptoms and physical findingsSupportive only: never classify on their own

Symptoms

Signs and decompensation red flags

Live result · computed in your browser

Caution

Caution

A medication or exposure relevant to thyroid interpretation is documented. Review its possible contribution before assigning a final etiology or management pathway.

Detected clinical pattern

Biochemical Pattern Compatible with Overt Primary Hypothyroidism

Elevated TSH with FT4 below the laboratory reference range supports this pattern.

  • Etiology / context: Medication/Exposure Modifier Present

Why this pattern was identified

  • Elevated TSH with low FT4. TSH 11.2 mIU/L (ref 0.4–4.5) and FT4 0.6 ng/dL (ref 0.8–1.8).
  • Medication/exposure documented. Amiodarone

Context modules routed

  • CTX-HT-DRUG Medication / Exposure Modifier

    Flag possible drug- or exposure-associated thyroid dysfunction; do not automatically assign autoimmune etiology; consider specialist review for complex medication-related patterns.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Confirm clinical context, etiology modifiers and medication/exposure history.
  2. 2Consider lipid panel, CBC and CK if clinically indicated.
  3. 3Physician to determine levothyroxine initiation and dose using age and cardiovascular context.
Evidence and rule trace · 2 rules

PR-HT-01Overt Primary Hypothyroidism Biochemical Pattern

Inputs: TSH 11.2 mIU/L (ref 0.4–4.5) · FT4 0.6 ng/dL (ref 0.8–1.8)

TSH above and FT4 below the laboratory reference range.

CTX-HT-DRUGMedication / Exposure Modifier

Context module routed.

Evidence

  • EV-AACE-ATA-2012 · Garber JR et al. Clinical Practice Guidelines for Hypothyroidism in Adults. Endocr Pract. 2012;18(6):988-1028.
  • EV-ATA-HYPO-2014 · Jonklaas J et al. Guidelines for the Treatment of Hypothyroidism. Thyroid. 2014;24(12):1670-1751.

Physician adjudication required. For clinician review only. This output identifies clinical patterns and safety considerations from the documented inputs. It does not establish an autonomous diagnosis or treatment plan. Physician confirmation is required.

More thyroid cases

All thyroid cases

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod